By Allison Lampert and Jamie Freed
MONTREAL/SYDNEY (Reuters) - Aviation industry opposition to requiring mandatory COVID-19 vaccination for passengers has intensified as impending drug approvals trigger a debate over their role in air travel.
Airports Council International, which represents airports worldwide, joined most airlines in calling for a choice between testing or vaccination, fearing a blanket rule imposing pre-flight inoculation would be as disruptive as quarantines.
Qantas Airways triggered the debate last week when it said a COVID-19 vaccination would be necessary for passengers on its international flights, which remain largely idle because of Australia's strict border controls.
But other airlines, and now global airports, are worried that waiting for vaccines would bar people from traveling until they are rolled out widely, crippling business in regions, such as Europe that have relatively small domestic aviation markets.
"Just as quarantine effectively halted the industry, a universal requirement for vaccines could do the same," ACI World Director General Luis Felipe de Oliveira told Reuters.
"While we welcome the rapid development and deployment of vaccines, there will be a considerable period before they are widely available," he added.
"The industry cannot wait till vaccination becomes available worldwide. During the transition period, tests and vaccines together will play a key role on the industry recovery."
Australia has indicated people arriving from abroad will need to be vaccinated or to self-isolate in one of a limited number of hotels.
Qantas Chief Executive Alan Joyce said the policy could spread to other countries, noting proof of vaccination is already required for yellow fever for some destinations.
"Other governments are moving in that direction," he told reporters on Thursday.
TESTING OR VACCINES?
But the head of airline trade group IATA, which last week downgraded its financial outlook for the sector as a second wave of COVID-19 cases swept Europe and the United States, believes making vaccines compulsory would not work globally.
Systematic testing is "more critical to reopening borders than the vaccine", IATA Director General Alexandre de Juniac told Reuters.
Shukor Yusof, head of Malaysia-based aviation consultancy Endau Analytics, said Southeast Asian countries would take different approaches on vaccine requirements. Asian countries have some of the lowest case numbers of the novel coronavirus globally.
Taiwan Health Minister Chen Shih-chung said on Wednesday that COVID-19 "passports" to show inoculation and infection history are a good idea, but hard in practice. [L1N2II0FV]
Australian Prime Minister Scott Morrison called on Thursday for a common set of global recognitions for COVID-19 vaccines.
Some experts say vaccines will be difficult to mandate because of limited supply and a range of quality.
Dr David Freedman, a U.S. infectious diseases specialist, believes more countries will follow Britain's lead and use testing to reduce quarantine times.
"For the majority of the world's population, especially in the developing world, it's going to be years before everybody that wants to fly even has the possibility of getting the vaccine," said Freedman, a professor at University of Alabama at Birmingham.
As more countries develop vaccines, airlines and governments will need to decide which ones to clear.
"The other issue about mandatory vaccines is going to be well what vaccine did you get?" Freedman said. "Do we trust every vaccine that's made in the world?"
(Reporting By Allison Lampert and Jamie Freed; additional reporting by Asia bureaus; editing by Barbara Lewis)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)